Gross Margin

With revenue down 22% and losses widening, JCTC's Q3 looks grim. But a stronger balance sheet and insider buying hint at a deliberate, high-stakes pivot.

As Ribbon Communications prepares its Q2 results, investors watch for proof that its AI and optical growth can overcome market headwinds and project delays.

A 44% profit jump on flat volume? NextNRG's AI-driven efficiency shows a future where energy value is created by algorithms, not just output.

As solar tracker giant Array Technologies preps its Q2 results, we look beyond the numbers at the market forces and strategic shifts defining the industry.

After a disastrous quarter, less-lethal tech firm Byrna Technologies is cutting operations, acquiring a rival, and betting its future on a major marketing blitz.

Ultragenyx bets 62% of its budget on R&D while unprofitable. Its new Impact Report reveals a strategy where patient access and ESG are the real assets.

The RF tech firm's dual move to repurchase shares and terminate its ATM offering signals robust financial health and a strategic pivot to enhance shareholder value.

A Nasdaq firm boasts impressive crypto yields and a vision to audit AI. But beneath the stable facade, it's built on a token that has lost 98% of its value.

As Merit Medical preps its Q2 report, investors are watching more than numbers. Key acquisitions and product launches signal a deeper strategic shift.

China Yuchai's robust dividend reflects a stellar 2025, but the real story is its deep investment in electric, hybrid, and fuel cell tech for a new era.

The luxury audio giant celebrated 100 years with record profits but a sales dip and a product misstep reveal a complex path forward for its next century.

National Beverage Corp. wraps a massive special dividend in the American flag. Is it a financial masterstroke, a branding coup, or a new model for trust?

Polestar swaps massive debt for equity, tightening its bond with Geely and Volvo. The move shores up its finances but raises questions about its future.

XPeng posts a 65% sequential jump in Q2 deliveries, meeting guidance. But flat yearly growth highlights brutal competition as it bets on new mass-market models.

QDM International's 179% revenue jump is stunning, but soaring costs and a pivot to AI reveal the high-stakes game of survival in Hong Kong's new economy.

After a brutal $4.9M loss driven by product obsolescence, the avionics firm is betting its future on major defense contracts. But can it navigate tight cash?

Texxon Holding's net loss and revenue plunge signal deep industry woes. But can a 40% surge in its plastics unit and a new factory turn the tide?

With its third CEO in a year, Rocky Mountain Chocolate Factory bets on a familiar face. But as shares plunge, the move raises questions about the path to recovery.

By partnering with manufacturing giant Sanmina, Microbot Medical is telegraphing its shift from a promising MedTech firm to a serious global contender.